| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comparison of hormonal profiles between breast cancer and benign breast disease: a case–control study
|
Lagiou, P.
|
|
|
24 |
10 |
p. 2527-2533
|
artikel
|
| 2 |
A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients
|
Wilgenhof, S.
|
|
|
24 |
10 |
p. 2686-2693
|
artikel
|
| 3 |
A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer
|
Kelly, R.J.
|
|
|
24 |
10 |
p. 2601-2606
|
artikel
|
| 4 |
A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer
|
Kadalayil, L.
|
|
|
24 |
10 |
p. 2565-2570
|
artikel
|
| 5 |
Attitude of employees of a university clinic to complementary and alternative medicine in oncology
|
Trimborn, A.
|
|
|
24 |
10 |
p. 2641-2645
|
artikel
|
| 6 |
Cancer mortality in Europe, 2005–2009, and an overview of trends since 1980
|
Bosetti, C.
|
|
|
24 |
10 |
p. 2657-2671
|
artikel
|
| 7 |
Cancer patients and survivors: changing words or changing culture?
|
Surbone, A.
|
|
|
24 |
10 |
p. 2468-2471
|
artikel
|
| 8 |
Clinical relevance of cancer stem cells in bone marrow of early breast cancer patients
|
Giordano, A.
|
|
|
24 |
10 |
p. 2515-2521
|
artikel
|
| 9 |
Comparison of pixantrone-based regimen (CPOP-R) with doxorubicin-based therapy (CHOP-R) for treatment of diffuse large B-cell lymphoma
|
Herbrecht, R.
|
|
|
24 |
10 |
p. 2618-2623
|
artikel
|
| 10 |
Correlation between overall survival and growth modulation index in pre-treated sarcoma patients: a study from the French Sarcoma Group †
|
Cousin, S.
|
|
|
24 |
10 |
p. 2681-2685
|
artikel
|
| 11 |
Detection of aberrant methylation of 10 genes in genomic DNA of lung tumors
|
Sheikhnejad, R.
|
|
|
24 |
10 |
p. 2705-2706
|
artikel
|
| 12 |
Diagnostic value of a novel fully automated immunochemistry assay for detection of ALK rearrangement in primary lung adenocarcinoma
|
Ying, J.
|
|
|
24 |
10 |
p. 2589-2593
|
artikel
|
| 13 |
Dietary intake of acrylamide and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
|
Obón-Santacana, M.
|
|
|
24 |
10 |
p. 2645-2651
|
artikel
|
| 14 |
Distinct outcome of stage I lung adenocarcinoma with ACTN4 cell motility gene amplification
|
Noro, R.
|
|
|
24 |
10 |
p. 2594-2600
|
artikel
|
| 15 |
Editorial board
|
|
|
|
24 |
10 |
p. ii-iii
|
artikel
|
| 16 |
Efficacy and safety of ipilimumab in metastatic melanoma patients surviving more than 2 years following treatment in a phase III trial (MDX010-20)
|
McDermott, D.
|
|
|
24 |
10 |
p. 2694-2698
|
artikel
|
| 17 |
Emerging approaches for treating HER2-positive metastatic breast cancer beyond trastuzumab
|
Gradishar, W.J.
|
|
|
24 |
10 |
p. 2492-2500
|
artikel
|
| 18 |
Equipoise abandoned? Randomization and clinical trials
|
Kurzrock, R.
|
|
|
24 |
10 |
p. 2471-2474
|
artikel
|
| 19 |
Expression and mutational status of treatment-relevant targets and key oncogenes in 123 malignant salivary gland tumours
|
Cros, J.
|
|
|
24 |
10 |
p. 2624-2629
|
artikel
|
| 20 |
Family history of cancer and the risk of cancer: a network of case–control studies
|
Turati, F.
|
|
|
24 |
10 |
p. 2651-2656
|
artikel
|
| 21 |
Functional proteomics characterization of residual triple-negative breast cancer after standard neoadjuvant chemotherapy
|
Sohn, J.
|
|
|
24 |
10 |
p. 2522-2526
|
artikel
|
| 22 |
Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer
|
Cortés, J.
|
|
|
24 |
10 |
p. 2630-2635
|
artikel
|
| 23 |
Impact of excision repair cross-complementing gene 1 (ERCC1) on the outcomes of patients with advanced gastric cancer: correlative study in Japan Clinical Oncology Group Trial JCOG9912
|
Yamada, Y.
|
|
|
24 |
10 |
p. 2560-2565
|
artikel
|
| 24 |
Informal caregiving to older cancer patients: preliminary research outcomes and implications
|
Goldzweig, G.
|
|
|
24 |
10 |
p. 2635-2640
|
artikel
|
| 25 |
Information to women invited to mammography screening
|
Njor, S.H.
|
|
|
24 |
10 |
p. 2467-2468
|
artikel
|
| 26 |
Likelihood of early detection of breast cancer in relation to false-positive risk in life-time mammographic screening: population-based cohort study
|
Otten, J.D.M.
|
|
|
24 |
10 |
p. 2501-2506
|
artikel
|
| 27 |
Limb preservation surgery with extracorporeal irradiation in the management of malignant bone tumor: the oncological outcomes of 101 patients
|
Hong, A.M.
|
|
|
24 |
10 |
p. 2676-2680
|
artikel
|
| 28 |
Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSA
|
Trebouet, A.
|
|
|
24 |
10 |
p. 2612-2618
|
artikel
|
| 29 |
Multicenter phase II trial to investigate safety and efficacy of gemcitabine combined with cetuximab as adjuvant therapy in pancreatic cancer (ATIP)
|
Fensterer, H.
|
|
|
24 |
10 |
p. 2576-2581
|
artikel
|
| 30 |
Needs regarding care and factors associated with unmet needs in disease-free survivors of surgically treated lung cancer
|
|
|
|
24 |
10 |
p. 2707
|
artikel
|
| 31 |
Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer
|
Heinemann, V.
|
|
|
24 |
10 |
p. 2484-2492
|
artikel
|
| 32 |
N0539 phase II trial of fulvestrant and bevacizumab in patients with metastatic breast cancer previously treated with an aromatase inhibitor: a North Central Cancer Treatment Group (now Alliance) trial †
|
Tan, W.W.
|
|
|
24 |
10 |
p. 2548-2554
|
artikel
|
| 33 |
Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients
|
Jiralerspong, S.
|
|
|
24 |
10 |
p. 2506-2514
|
artikel
|
| 34 |
Primary tumor location and bevacizumab effectiveness in patients with metastatic colorectal cancer
|
Boisen, M.K.
|
|
|
24 |
10 |
p. 2554-2559
|
artikel
|
| 35 |
Prognostic role of microRNA polymorphisms in advanced gastric cancer: a translational study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
|
Stenholm, L.
|
|
|
24 |
10 |
p. 2581-2588
|
artikel
|
| 36 |
Prognostic value of the trichorhinophalangeal syndrome-1 (TRPS-1), a GATA family transcription factor, in early-stage breast cancer
|
Chen, J.Q.
|
|
|
24 |
10 |
p. 2534-2542
|
artikel
|
| 37 |
Randomized phase II study of lonaprisan as second-line therapy for progesterone receptor-positive breast cancer
|
Jonat, W.
|
|
|
24 |
10 |
p. 2543-2548
|
artikel
|
| 38 |
Red meat, Mediterranean diet and lung cancer risk among heavy smokers in the COSMOS screening study
|
Gnagnarella, P.
|
|
|
24 |
10 |
p. 2606-2611
|
artikel
|
| 39 |
Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer
|
|
|
|
24 |
10 |
p. 2708-2710
|
artikel
|
| 40 |
Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis—an EORTC STBSG and ROG study (EORTC 62991–22998)
|
Keus, R.B.
|
|
|
24 |
10 |
p. 2672-2676
|
artikel
|
| 41 |
Table of Contents
|
|
|
|
24 |
10 |
p. iv-vi
|
artikel
|
| 42 |
The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials
|
Lyman, G.H.
|
|
|
24 |
10 |
p. 2475-2484
|
artikel
|
| 43 |
TNF-α gene promoter polymorphisms and risk of venous thromboembolism in gastrointestinal cancer patients undergoing chemotherapy
|
Roselli, M.
|
|
|
24 |
10 |
p. 2571-2575
|
artikel
|
| 44 |
Tobacco smoking and the risk of subsequent primary cancer among cancer survivors: a retrospective cohort study
|
Tabuchi, T.
|
|
|
24 |
10 |
p. 2699-2704
|
artikel
|
Tijdschrift beschrijving